These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 15129469)
1. Hyperinsulinaemia. Phillips P Aust Fam Physician; 2004 Apr; 33(4):241-2. PubMed ID: 15129469 [No Abstract] [Full Text] [Related]
2. Metabolic syndrome: is it a syndrome? Does it matter? Kahn R Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171 [No Abstract] [Full Text] [Related]
3. Insulin resistance syndrome: a potent culprit in cardiovascular disease. Coulston AM; Peragallo-Dittko V J Am Diet Assoc; 2004 Feb; 104(2):176-9. PubMed ID: 14760563 [No Abstract] [Full Text] [Related]
4. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402 [TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes: the role of insulin. Brunton S; Carmichael B; Funnell M; Lorber D; Rakel R; Rubin R J Fam Pract; 2005 May; 54(5):445-52. PubMed ID: 15865903 [No Abstract] [Full Text] [Related]
7. Toward an improved diagnosis of the metabolic syndrome other clues to the presence of insulin resistance. Cohn GS; Kittleson MM; Blumenthal RS Am J Hypertens; 2005 Aug; 18(8):1099-103. PubMed ID: 16109324 [TBL] [Abstract][Full Text] [Related]
8. New insights into understanding cardiometabolic risk. Introduction. Fonarow GC; Watson KE Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389 [No Abstract] [Full Text] [Related]
9. Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients? Monami M; Lambertucci L; Ungar A; Pieri M; Masotti G; Marchionni N; Mannucci E Diabetes Care; 2006 Nov; 29(11):2515-7. PubMed ID: 17065696 [No Abstract] [Full Text] [Related]
10. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Ahmed I; Goldstein BJ Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936 [TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations. Zarich SW Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752 [TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-restricted versus low-glycemic-index diets for the treatment of insulin resistance and metabolic syndrome. Wood RJ; Fernandez ML Nutr Rev; 2009 Mar; 67(3):179-83. PubMed ID: 19239633 [TBL] [Abstract][Full Text] [Related]
14. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284 [TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Gaspard U Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194 [TBL] [Abstract][Full Text] [Related]